Company Filing History:
5 out of 4,770 
3 out of 1,457 
1 out of 2,405 
Years Active: 1998-2021
Title: Rosemarie Kelly: Pioneering Inventor in Fungal Drug Resistance Detection
Introduction:
Rosemarie Kelly, a brilliant inventor based in Westfield, NJ, has made significant contributions in the field of fungal drug resistance detection. With an impressive portfolio of 7 patents, Kelly is paving the way for more effective identification and treatment of fungal infections.
Latest Patents:
One of Kelly's latest patents includes assays for resistance to echinocandin-class drugs. These nucleic acid amplification assays target mutations in two short sections of the fungal gene FKS1, which have been linked to resistance to echinocandin-class drugs. The assays utilize detection methods such as sequencing and labeled hybridization probes, along with primers, probes, and reagent kits for comprehensive testing.
Career Highlights:
Kelly has played an instrumental role in various esteemed organizations, including Merck & Company, Inc. and Rutgers, the State University of New Jersey. His expertise and innovative solutions have significantly impacted the field of pharmaceuticals and medical research, earning him recognition as a trailblazer in fungal drug resistance detection.
Collaborations:
During his career, Kelly has collaborated with talented individuals such as Cameron M Douglas and Jennifer Nielsen Kahn. Together, they have worked on groundbreaking projects that have pushed the boundaries of scientific discovery and advanced the fight against drug-resistant fungal infections.
Conclusion:
In conclusion, Rosemarie Kelly's pioneering work in fungal drug resistance detection stands as a testament to his ingenuity and dedication to advancing medical research. His patents and collaborations highlight his significant contributions to the field, setting a high standard for innovation in the fight against drug-resistant fungal infections.